April 2020: an ambulance picks up a possible covid patient near Liège. Whether the pill really makes a difference – and thus reduces the risk of hospitalization – will be known in September or October. — © afp
The drug company Merck is investigating whether molnupiravir can prevent the first symptoms from derailing into severe covid-19. It is one of the few drugs in the pipeline to avoid hospital admissions.
Read Also
- Petrangolini (Altems): “Strong patient associations activism with Covid” Sep 17, 2021
- The UAE flies a fifth medical supply plane to Mauritania Sep 8, 2021
- Cash not only survived the pandemic – it came out stronger Sep 1, 2021
- Cecilia Bracamonte announces her return to the stage Sep 2, 2021
- Called garnish, which is useful every day Aug 9, 2020
- Covid, epidemiologist Ciccozzi: ‘Even the division between scientists has confused’ Sep 15, 2021
- Global Market In Vitro Fertilization 2021 Growth Factors, Types and Application by Regional Geography 2024 – RF Online Apr 20, 2021
Maxie Eckert
Today at 11:34 AM
.
